Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1500034	奈韦拉平口服混悬液	nevirapine	Suspension	Chemical Drugs	Supplementary Application	2015-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2015-05-12	view
J0301578	奈韦拉平口服混悬液	nevirapine	Suspension	Chemical Drugs	License Renew	2003-11-05		Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd	Certificate Issued	2004-07-05	view
JYHZ1400514	奈韦拉平口服混悬液	nevirapine	Suspension	Chemical Drugs	License Renew	2014-09-02	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2016-12-16	view
JYHZ1400515	奈韦拉平口服混悬液	nevirapine	Suspension	Chemical Drugs	License Renew	2014-08-13	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2016-12-16	view
JYHB1800493	奈韦拉平口服混悬液	nevirapine	Suspension	Chemical Drugs	Supplementary Application	2018-05-14	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-01-02	view
JYHB1300243	奈韦拉平口服混悬液	nevirapine	Suspension	Chemical Drugs	Supplementary Application	2013-02-21	勃林格殷格翰国际贸易（上海）有限公司	Boehringer Ingelheim International Trading (Shanghai) Co Ltd	Certificate Issued	2013-09-18	view